SCHEMBL291282

SCHEMBL291282

NCCCC(=O)ON

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1064212 0.92
SCHEMBL108650 0.90 LMNA (0.54)
SCHEMBL3732920 0.90 LMNA (0.54)
SCHEMBL4372219 0.90 LMNA (0.54)
Hydrochloric Acid SCHEMBL28931234 0.90 BLM (0.54)
SCHEMBL14720655 0.90 LMNA (0.54)
SCHEMBL4374451 0.90 LMNA (0.54)
SCHEMBL4372734 0.90 LMNA (0.54)
SCHEMBL1060951 0.85 TSHR (0.50)
SCHEMBL275122 0.85 TSHR (0.43)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 550 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3750995-B1 PEPTIDE NUCLEIC ACID COMPLEX HAVING ENDOSOMAL ESCAPE CAPACITY, AND USE THEREOF SEASUN THERAPEUTICS INC (KR) 2024-12-25 EP claimed
CN-117126248-A Novel heterodimer positron emission tomography developer 核欣(苏州)医药科技有限公司 2023-11-28 CN claimed
WO-2023196194-A2 SKIN CARE COMPOSITIONS COLGATE-PALMOLIVE COMPANY (US) 2023-10-12 WO claimed
US-20230193275-A1 PEPTIDE NUCLEIC ACID COMPLEX HAVING ENDOSOMAL ESCAPE CAPACITY, AND USE THEREOF SEASUN THERAPEUTICS INC (KR) 2023-06-22 US claimed
EP-3498844-B1 PEPTIDE NUCLEIC ACID COMPLEX HAVING IMPROVED CELL PERMEABILITY AND PHARMACEUTICAL COMPOSITION COMPRISING SAME SEASUN THERAPEUTICS (KR) 2022-09-28 EP claimed
EP-4047094-A1 PEPTIDE-NUCLEIC ACID COMPLEX HAVING BLOOD-BRAIN BARRIER PENETRATION ABILITY AND COMPOSITION COMPRISING SAME Seasun Therapeutics (KR) 2022-08-24 EP claimed
US-20220169688-A1 SELECTIVE TARGETING OF UBIQUITIN- AND UBIQUITIN-LIKE E1-ACTIVATING ENZYMES BY STRUCTURALLY-STABILIZED PEPTIDES NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2022-06-02 US claimed
US-20220125935-A1 COMPOSITION FOR PREVENTING OR TREATING ATOPIC DERMATITIS COMPRISING SKIN-PENETRATING NUCLEIC ACID COMPLEX AS EFFECTIVE COMPONENT SEASUN THERAPEUTICS (KR) 2022-04-28 US claimed
EP-3962933-A1 SELECTIVE TARGETING OF UBIQUITIN- AND UBIQUITIN-LIKE E1-ACTIVATING ENZYMES BY STRUCTURALLY-STABILIZED PEPTIDES Dana-Farber Cancer Institute, Inc. (US) 2022-03-09 EP claimed
US-11147872-B2 Multivalent glycoconjugate vaccines BIOSYNTH S.R.L. (IT) 2021-10-19 US claimed
WO-2003014158-A1 SOMATOSTATIN ANALOGUES AND THEIR USE SOMATOSTATIN ANALOGUES BINDING TO ALL SOMATOSTATIN RECEPTOR AND THEIR USE UNIVERSITY OF BERN (CH) 2003-02-20 WO claimed
EP-1283216-A1 Somatostatin analogues binding to all somatostatin receptor subtypes and their use Mallinckrodt Inc. (US) 2003-02-12 EP claimed
EP-1220902-A2 CONJUGATES BETWEEN A PEPTIDE AND A NUCLEIC ACID ANALOG, SUCH AS A PNA, LNA OR A MORPHOLINO Pantheco A/S (DK) 2002-07-10 EP claimed
US-20020052315-A1 Conformationally constrained backbone cyclized somatostatin analogs CORTENDO AB (PUBL) 2002-05-02 US claimed
WO-2001027261-A2 CONJUGATES BETWEEN A PEPTIDES AND A NUCLEIC ACID ANALOG, SUCH AS A PNA, LNA OR A MORPHOLINO PANTHECO A/S (DK) 2001-04-19 WO claimed
EP-1085896-A1 CONFORMATIONALLY CONSTRAINED BACKBONE CYCLIZED SOMATOSTATIN ANALOGS PEPTOR LTD (IL) 2001-03-28 EP claimed
WO-1999065508-A1 CONFORMATIONALLY CONSTRAINED BACKBONE CYCLIZED SOMATOSTATIN ANALOGS PEPTOR LTD. (IL) 1999-12-23 WO claimed
EP-0192492-B1 PEPTIDES CONTAINING AN ALIPHATIC-AROMATIC KETONE SIDE CHAIN THE SALK INSTITUTE FOR BIOLOGICAL STUDIES (US) 1992-01-02 EP claimed
US-5019383-A Synthetic Vaccines NEW YORK BLOOD CENTER, INC. (US) 1991-05-28 US claimed
EP-0307860-A2 Cyclic GRF-analogs F. HOFFMANN-LA ROCHE AG (CH) 1989-03-22 EP claimed